ES2942748T3 - Sistema para la supervisión y gestión del bienestar y la nutrición utilizando datos de analito - Google Patents
Sistema para la supervisión y gestión del bienestar y la nutrición utilizando datos de analito Download PDFInfo
- Publication number
- ES2942748T3 ES2942748T3 ES18712038T ES18712038T ES2942748T3 ES 2942748 T3 ES2942748 T3 ES 2942748T3 ES 18712038 T ES18712038 T ES 18712038T ES 18712038 T ES18712038 T ES 18712038T ES 2942748 T3 ES2942748 T3 ES 2942748T3
- Authority
- ES
- Spain
- Prior art keywords
- analyte
- reader device
- sensor
- food
- curve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 247
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 25
- 230000035764 nutrition Effects 0.000 title claims abstract description 20
- 238000012544 monitoring process Methods 0.000 title abstract description 43
- 235000013305 food Nutrition 0.000 claims abstract description 70
- 235000012054 meals Nutrition 0.000 claims abstract description 55
- 238000001727 in vivo Methods 0.000 claims abstract description 31
- 238000005259 measurement Methods 0.000 claims abstract description 31
- 238000004891 communication Methods 0.000 claims abstract description 26
- 230000004044 response Effects 0.000 claims abstract description 26
- 230000037081 physical activity Effects 0.000 claims abstract description 14
- 210000001124 body fluid Anatomy 0.000 claims abstract description 11
- 239000010839 body fluid Substances 0.000 claims abstract description 8
- 230000015654 memory Effects 0.000 claims description 39
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 34
- 239000008103 glucose Substances 0.000 claims description 34
- 230000006870 function Effects 0.000 claims description 12
- 230000036642 wellbeing Effects 0.000 claims description 7
- 230000001186 cumulative effect Effects 0.000 claims 4
- 238000012806 monitoring device Methods 0.000 abstract description 29
- 238000000034 method Methods 0.000 abstract description 17
- 235000015097 nutrients Nutrition 0.000 abstract description 15
- 238000013519 translation Methods 0.000 abstract 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 18
- 150000001720 carbohydrates Chemical class 0.000 description 16
- 235000014633 carbohydrates Nutrition 0.000 description 16
- 150000002576 ketones Chemical class 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 208000007976 Ketosis Diseases 0.000 description 11
- 230000004140 ketosis Effects 0.000 description 11
- 235000005911 diet Nutrition 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000003442 weekly effect Effects 0.000 description 8
- 230000037213 diet Effects 0.000 description 7
- 238000007726 management method Methods 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 230000001052 transient effect Effects 0.000 description 7
- 208000017667 Chronic Disease Diseases 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 4
- 235000021152 breakfast Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 230000037147 athletic performance Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000006855 networking Effects 0.000 description 2
- 235000015927 pasta Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical class CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000001280 Prediabetic State Diseases 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 102100038358 Prostate-specific antigen Human genes 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 108090001027 Troponin Proteins 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 230000001667 episodic effect Effects 0.000 description 1
- 235000021197 fiber intake Nutrition 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- IXZISFNWUWKBOM-ARQDHWQXSA-N fructosamine Chemical compound NC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O IXZISFNWUWKBOM-ARQDHWQXSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 235000020887 ketogenic diet Nutrition 0.000 description 1
- 230000002361 ketogenic effect Effects 0.000 description 1
- 229910052451 lead zirconate titanate Inorganic materials 0.000 description 1
- HFGPZNIAWCZYJU-UHFFFAOYSA-N lead zirconate titanate Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Zr+4].[Pb+2] HFGPZNIAWCZYJU-UHFFFAOYSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000020855 low-carbohydrate diet Nutrition 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004984 smart glass Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229910052613 tourmaline Inorganic materials 0.000 description 1
- 239000011032 tourmaline Substances 0.000 description 1
- 229940070527 tourmaline Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000011845 white flour Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4866—Evaluating metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/002—Monitoring the patient using a local or closed circuit, e.g. in a room or building
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
- A61B5/1118—Determining activity level
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Optics & Photonics (AREA)
- Physiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Dentistry (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762468843P | 2017-03-08 | 2017-03-08 | |
| PCT/US2018/020030 WO2018164886A1 (en) | 2017-03-08 | 2018-02-27 | Systems, devices, and methods for wellness and nutrition monitoring and management using analyte data |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2942748T3 true ES2942748T3 (es) | 2023-06-06 |
Family
ID=61691562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18712038T Active ES2942748T3 (es) | 2017-03-08 | 2018-02-27 | Sistema para la supervisión y gestión del bienestar y la nutrición utilizando datos de analito |
Country Status (11)
| Country | Link |
|---|---|
| US (7) | US20180256103A1 (enExample) |
| EP (2) | EP3592213B1 (enExample) |
| JP (2) | JP7609559B2 (enExample) |
| CN (2) | CN110392547A (enExample) |
| AU (2) | AU2018230850B2 (enExample) |
| CA (1) | CA3055242A1 (enExample) |
| DK (1) | DK3592213T3 (enExample) |
| ES (1) | ES2942748T3 (enExample) |
| FI (1) | FI3592213T3 (enExample) |
| LT (1) | LT3592213T (enExample) |
| WO (1) | WO2018164886A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2432377A1 (en) | 2009-05-22 | 2012-03-28 | Abbott Diabetes Care, Inc. | Usability features for integrated insulin delivery system |
| DK3988470T3 (da) | 2009-08-31 | 2023-08-28 | Abbott Diabetes Care Inc | Visningsindretninger til en medicinsk indretning |
| WO2014085602A1 (en) | 2012-11-29 | 2014-06-05 | Abbott Diabetes Care Inc. | Methods, devices, and systems related to analyte monitoring |
| US11004566B2 (en) * | 2015-07-06 | 2021-05-11 | Abbott Diabetes Care Inc. | Systems, devices, and methods for episode detection and evaluation |
| US10092207B1 (en) | 2016-05-15 | 2018-10-09 | Biolinq, Inc. | Tissue-penetrating electrochemical sensor featuring a co-electrodeposited thin film comprised of polymer and bio-recognition element |
| US12109032B1 (en) | 2017-03-11 | 2024-10-08 | Biolinq Incorporated | Methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure |
| US11045142B1 (en) | 2017-04-29 | 2021-06-29 | Biolinq, Inc. | Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry |
| ES3036843T3 (en) * | 2018-02-05 | 2025-09-24 | Abbott Diabetes Care Inc | Notes and event log information associated with analyte sensors |
| JP7316358B2 (ja) * | 2018-11-29 | 2023-07-27 | ジャニュアリー， インコーポレイテッド | 生物物理学的モデル化および応答予測のためのシステム、方法、およびデバイス |
| US11664108B2 (en) | 2018-11-29 | 2023-05-30 | January, Inc. | Systems, methods, and devices for biophysical modeling and response prediction |
| US11484210B1 (en) * | 2019-06-20 | 2022-11-01 | Waleed Bahaa El Deen Abdul Raheem Ahmed | Methods and systems for early detection of diabetes and advising those considered pre diabetic or diabetic |
| US11688505B2 (en) | 2019-07-03 | 2023-06-27 | Kpn Innovations, Llc. | Methods and systems for generating a supplement instruction set using artificial intelligence |
| US11449792B2 (en) | 2019-07-03 | 2022-09-20 | Kpn Innovations, Llc. | Methods and systems for generating a supplement instruction set using artificial intelligence |
| US11154223B2 (en) * | 2019-08-30 | 2021-10-26 | TT1 Products, Inc. | Biomarker monitoring fitness system |
| US11744561B2 (en) * | 2019-11-07 | 2023-09-05 | Smylio Inc. | Saliva collection and testing system |
| US11244753B2 (en) | 2020-01-30 | 2022-02-08 | Medtronic Minimed, Inc. | Activity monitoring systems and methods |
| EP4114263A4 (en) * | 2020-03-02 | 2024-04-10 | Dexcom, Inc. | Evaluation of data to provide decision support for a ketogenic lifestyle |
| ES3037549T3 (en) * | 2020-03-11 | 2025-10-03 | Abbott Diabetes Care Inc | Graphical user interfaces for analyte monitoring systems |
| WO2021195614A1 (en) * | 2020-03-27 | 2021-09-30 | Salvus, Llc | System and method for analyte detection and decontamination certification |
| WO2021247742A1 (en) * | 2020-06-03 | 2021-12-09 | Abbott Diabetes Care Inc. | Analyte monitoring systems and methods |
| US12502102B2 (en) * | 2020-07-01 | 2025-12-23 | Abbott Diabetes Care Inc. | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation |
| EP4647772A3 (en) | 2020-07-29 | 2025-12-24 | Biolinq, Inc. | Continuous analyte monitoring system with microneedle array |
| US11284818B2 (en) | 2020-08-31 | 2022-03-29 | TT1 Products, Inc. | Glucose exposure diagnostics and therapeutics related thereto |
| US11467857B2 (en) * | 2020-10-13 | 2022-10-11 | Adobe Inc. | Intelligently sensing digital user context to generate recommendations across client device applications |
| CN116829069A (zh) | 2021-01-29 | 2023-09-29 | 雅培糖尿病护理公司 | 第三方分析物监测 |
| JP7185976B1 (ja) * | 2021-02-03 | 2022-12-08 | 株式会社健康再生研究所 | 食生活評価システム及び食生活評価方法 |
| US11544923B2 (en) | 2021-03-12 | 2023-01-03 | Agot Co. | Image-based kitchen tracking system with order accuracy management |
| CA3184224A1 (en) | 2021-05-08 | 2022-11-17 | Joshua Ray Windmiller | Fault detection for microneedle array based continuous analyte monitoring device |
| USD1004777S1 (en) | 2021-09-01 | 2023-11-14 | TT1 Products, Inc. | Wrist reader |
| WO2023043797A1 (en) * | 2021-09-15 | 2023-03-23 | Abbott Diabetes Care Inc. | Systems, devices, and methods for applications for communication with ketone sensors |
| FR3128367B1 (fr) | 2021-10-27 | 2025-02-14 | Metyos | Procédé et système informatisés pour la détermination d’une recommandation nutritionnelle. |
| EP4456793A1 (en) * | 2021-12-30 | 2024-11-06 | Lingo Sensing Technology Unlimited Company | Systems, devices, and methods for wellness monitoring with physiological sensors |
| US12488312B2 (en) | 2022-07-12 | 2025-12-02 | Hme Hospitality & Specialty Communications, Inc. | Image-based kitchen tracking system with order accuracy management using sequence detection association |
| CN120569160A (zh) * | 2023-01-10 | 2025-08-29 | 凌格传感科技无限公司 | 利用生理传感器进行健康监测的系统、装置和方法 |
| CN120857905A (zh) | 2023-02-02 | 2025-10-28 | 比奥林公司 | 用于改善基于微针的连续分析物监测系统的传感器灵敏度的方法 |
| WO2025064882A2 (en) | 2023-09-22 | 2025-03-27 | Abbott Diabetes Care Inc. | Decision support for glucose-ketone sensor |
| WO2025146479A1 (en) * | 2024-01-04 | 2025-07-10 | Lingo Sensing Technology Unlimited Company | Systems, devices, and methods for wellness monitoring with physiological sensors |
| WO2025170538A1 (en) * | 2024-02-08 | 2025-08-14 | National University Of Singapore | Method for optimizing a health plan |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4114422A (en) * | 1975-01-02 | 1978-09-19 | Hutson Donald G | Method of monitoring diet |
| US20040197846A1 (en) * | 2001-01-18 | 2004-10-07 | Linda Hockersmith | Determination of glucose sensitivity and a method to manipulate blood glucose concentration |
| US7076371B2 (en) * | 2001-03-03 | 2006-07-11 | Chi Yung Fu | Non-invasive diagnostic and monitoring method and apparatus based on odor detection |
| US6585516B1 (en) * | 2002-01-09 | 2003-07-01 | Oliver Alabaster | Method and system for computerized visual behavior analysis, training, and planning |
| CA2479801A1 (en) * | 2002-03-26 | 2003-10-02 | Piet Moerman | A method and apparatus for quantifying caloric balance using metabolic parameters to assist subjects on weight management |
| US20050038680A1 (en) * | 2002-12-19 | 2005-02-17 | Mcmahon Kevin Lee | System and method for glucose monitoring |
| US20050159656A1 (en) * | 2003-03-07 | 2005-07-21 | Hockersmith Linda J. | Method and apparatus for presentation of noninvasive glucose concentration information |
| US20060173260A1 (en) * | 2005-01-31 | 2006-08-03 | Gmms Ltd | System, device and method for diabetes treatment and monitoring |
| US20090076360A1 (en) * | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
| DE602007002372D1 (de) * | 2007-01-29 | 2009-10-22 | Roche Diagnostics Gmbh | Beurteilungsverfahren zum Verarbeiten eines Glukosekonzentrationssignals |
| DK1972270T3 (da) * | 2007-03-23 | 2011-01-24 | Hoffmann La Roche | Fremgangsmåde og glucoseovervågningssystem til overvågning af individuelt metabolisk respons |
| DK2006786T3 (en) * | 2007-06-18 | 2018-08-06 | Hoffmann La Roche | Method and glucose monitoring system to monitor individual metabolic response and to generate nutrient feedback |
| AR075745A1 (es) * | 2008-05-28 | 2011-04-27 | Kraft Foods Global Brands Llc | Metodo y aparato para identificar opciones deseables, un metodo para ayu-dar a una persona a mantener una dieta predeterminada, un metodo para ro-tular items de alimento con un numero de calificacion relativa, un recipien-te que comprende una porcion de un item comestible dispuesto dentro del recipi |
| CN102281816B (zh) * | 2008-11-20 | 2015-01-07 | 人体媒介公司 | 用于确定危重护理参数的方法和设备 |
| US9913599B2 (en) | 2011-02-11 | 2018-03-13 | Abbott Diabetes Care Inc. | Software applications residing on handheld analyte determining devices |
| WO2012123765A1 (en) * | 2011-03-17 | 2012-09-20 | University Of Newcastle Upon Tyne | System for the self-monitoring and regulation of blood glucose |
| US8514067B2 (en) * | 2011-08-16 | 2013-08-20 | Elwha Llc | Systematic distillation of status data relating to regimen compliance |
| US9183757B2 (en) * | 2011-09-14 | 2015-11-10 | Ntt Docomo, Inc. | Dieting support system and dieting support method |
| EP4400043A3 (en) | 2011-09-28 | 2024-10-09 | Abbott Diabetes Care, Inc. | Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto |
| US20140142396A1 (en) | 2012-11-21 | 2014-05-22 | Nathan W. Ricks | Health Measurement Systems |
| US10867695B2 (en) * | 2012-06-04 | 2020-12-15 | Pharmalto, Llc | System and method for comprehensive health and wellness mobile management |
| US20140129151A1 (en) * | 2012-11-07 | 2014-05-08 | Dexcom, Inc. | Systems and methods for managing glycemic variability |
| WO2014145335A1 (en) | 2013-03-15 | 2014-09-18 | Abbott Diabetes Care Inc. | System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk |
| JP6417561B2 (ja) | 2013-03-15 | 2018-11-07 | アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． | 検体モニタリング装置と関連づけられた装置、システム、および方法、並びにそれらを組み込んだ装置 |
| WO2014153416A1 (en) * | 2013-03-19 | 2014-09-25 | University Of South Florida | Compositions and methods for producing elevated and sustained ketosis |
| AU2014260023B2 (en) * | 2013-04-30 | 2018-12-06 | Abbott Diabetes Care Inc. | Systems, devices, and methods for energy efficient electrical device activation |
| US10244964B2 (en) | 2013-09-06 | 2019-04-02 | University of Pittsburgh—of the Commonwealth System of Higher Education | Detection of acetone via nanostructure sensors |
| CN105899127B (zh) * | 2013-11-14 | 2019-09-24 | 加州大学董事会 | 血糖率上升检测器：用于健康监测系统的膳食检测模块 |
| JP6327606B2 (ja) | 2014-02-26 | 2018-05-23 | 株式会社タニタ | 摂取食事量提示装置、方法、及びプログラム |
| EP4151150B1 (en) | 2014-03-30 | 2025-08-27 | Abbott Diabetes Care Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
| US9459089B2 (en) * | 2014-04-09 | 2016-10-04 | Qualcomm Incorporated | Method, devices and systems for detecting an attachment of an electronic patch |
| US10453562B2 (en) * | 2014-05-08 | 2019-10-22 | ProductVisionaries, LLC | Consumer-oriented biometrics data management and analysis system |
| US10424219B2 (en) | 2015-05-07 | 2019-09-24 | Dexcom, Inc. | System and method for educating users, including responding to patterns |
| EP3311150A1 (en) * | 2015-06-18 | 2018-04-25 | Ultradian Diagnostics LLC | Methods and devices for determining metabolic states |
| CN108024765B (zh) * | 2015-07-10 | 2021-06-11 | 雅培糖尿病护理公司 | 对于生理参数进行动态葡萄糖曲线响应的系统、装置和方法 |
| US10888272B2 (en) * | 2015-07-10 | 2021-01-12 | Abbott Diabetes Care Inc. | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation |
| US20170053084A1 (en) * | 2015-08-21 | 2017-02-23 | Medtronic Minimed, Inc. | Data analytics and reporting of glucose-related information |
| EP3411717B1 (en) * | 2016-02-01 | 2025-08-20 | Dexcom, Inc. | System and method for decision support using lifestyle factors |
-
2018
- 2018-02-27 CN CN201880016734.5A patent/CN110392547A/zh active Pending
- 2018-02-27 CA CA3055242A patent/CA3055242A1/en active Pending
- 2018-02-27 EP EP18712038.1A patent/EP3592213B1/en active Active
- 2018-02-27 FI FIEP18712038.1T patent/FI3592213T3/fi active
- 2018-02-27 WO PCT/US2018/020030 patent/WO2018164886A1/en not_active Ceased
- 2018-02-27 DK DK18712038.1T patent/DK3592213T3/da active
- 2018-02-27 ES ES18712038T patent/ES2942748T3/es active Active
- 2018-02-27 US US15/907,183 patent/US20180256103A1/en active Pending
- 2018-02-27 LT LTEPPCT/US2018/020030T patent/LT3592213T/lt unknown
- 2018-02-27 EP EP23154616.9A patent/EP4218550A1/en active Pending
- 2018-02-27 AU AU2018230850A patent/AU2018230850B2/en active Active
- 2018-02-27 JP JP2019547626A patent/JP7609559B2/ja active Active
- 2018-02-27 CN CN202310735423.7A patent/CN116759088A/zh active Pending
-
2020
- 2020-09-24 US US17/031,595 patent/US20210007665A1/en not_active Abandoned
- 2020-09-24 US US17/031,548 patent/US20210000416A1/en not_active Abandoned
- 2020-09-24 US US17/031,527 patent/US20210000415A1/en not_active Abandoned
- 2020-09-24 US US17/031,577 patent/US20210007664A1/en not_active Abandoned
-
2022
- 2022-11-10 US US17/984,903 patent/US20230079165A1/en not_active Abandoned
-
2023
- 2023-06-01 JP JP2023090718A patent/JP2023116568A/ja active Pending
- 2023-06-22 US US18/339,787 patent/US20230337976A1/en active Pending
-
2024
- 2024-02-28 AU AU2024201322A patent/AU2024201322A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018230850B2 (en) | 2023-12-14 |
| US20210000416A1 (en) | 2021-01-07 |
| CN116759088A (zh) | 2023-09-15 |
| CA3055242A1 (en) | 2018-09-13 |
| AU2024201322A1 (en) | 2024-03-21 |
| EP4218550A1 (en) | 2023-08-02 |
| JP7609559B2 (ja) | 2025-01-07 |
| AU2018230850A1 (en) | 2019-09-26 |
| JP2023116568A (ja) | 2023-08-22 |
| US20210000415A1 (en) | 2021-01-07 |
| DK3592213T3 (da) | 2023-05-22 |
| CN110392547A (zh) | 2019-10-29 |
| LT3592213T (lt) | 2023-06-12 |
| FI3592213T3 (fi) | 2023-05-22 |
| US20210007665A1 (en) | 2021-01-14 |
| US20230337976A1 (en) | 2023-10-26 |
| EP3592213B1 (en) | 2023-03-22 |
| EP3592213A1 (en) | 2020-01-15 |
| US20180256103A1 (en) | 2018-09-13 |
| US20230079165A1 (en) | 2023-03-16 |
| WO2018164886A1 (en) | 2018-09-13 |
| US20210007664A1 (en) | 2021-01-14 |
| JP2020511214A (ja) | 2020-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2942748T3 (es) | Sistema para la supervisión y gestión del bienestar y la nutrición utilizando datos de analito | |
| ES3037549T3 (en) | Graphical user interfaces for analyte monitoring systems | |
| Mohammed et al. | Systems and WBANs for controlling obesity | |
| US20220248988A1 (en) | Digital and user interfaces for analyte monitoring systems | |
| US20180253991A1 (en) | Methods and Systems for Improving a Presentation Function of a Client Device | |
| JP6723952B2 (ja) | 非一時的コンピュータ可読媒体、デバイス及び方法 | |
| US10368811B1 (en) | Methods and devices for circadian rhythm monitoring | |
| EP3658013B1 (en) | Wearable fluidic system for measuring sweat composition | |
| US20140135592A1 (en) | Health band | |
| WO2010022387A1 (en) | Method and apparatus for chronic disease control | |
| US20250000463A1 (en) | Device and system user interfaces for chronic health condition management | |
| AU2023259147A1 (en) | Systems, devices, and methods for meal-related analyte response monitoring | |
| KR20190072137A (ko) | 건강관리 프로그램 제공방법 | |
| US11412962B1 (en) | Devices, systems, and methods for identifying improving health for chronic health condition management | |
| WO2025014790A1 (en) | Analyte monitoring systems | |
| Swaminathan | Aevum Personalized Health Monitoring System |